Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001104659-20-092727
Filing Date
2020-08-10
Accepted
2020-08-10 16:13:44
Documents
11
Effectiveness Date
2020-08-10

Document Format Files

Seq Description Document Type Size
1 FORM S-3ASR tm2026919-1_s3asr.htm S-3ASR 439836
2 EXHIBIT 4.1 tm2026919d2_ex4-1.htm EX-4.1 361810
3 EXHIBIT 4.2 tm2026919d2_ex4-2.htm EX-4.2 374524
4 EXHIBIT 4.3 tm2026919d2_ex4-3.htm EX-4.3 38740
5 EXHIBIT 4.4 tm2026919d2_ex4-4.htm EX-4.4 38586
6 EXHIBIT 5.1 tm2026919d2_ex5-1.htm EX-5.1 34625
7 EXHIBIT 23.1 tm2026919d2_ex23-1.htm EX-23.1 2626
8 EXHIBIT 23.2 tm2026919d2_ex23-2.htm EX-23.2 2860
9 GRAPHIC lg-ptctherapeuti_bw.jpg GRAPHIC 107847
10 GRAPHIC tm2026919d2_ex5-1img001.jpg GRAPHIC 2029
11 GRAPHIC tm2026919d2_ex5-1img002.jpg GRAPHIC 7015
  Complete submission text file 0001104659-20-092727.txt   1456153
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-243712 | Film No.: 201089517
SIC: 2834 Pharmaceutical Preparations